Abstract. The aim of the present study was to investigate the anticancer activities of Nelumbo nucifera (Ba lotus) stamen ethanol crude extract (BLSEE) in human colon carcinoma HCT-116 cells. MTT assay, flow cytometry analysis and reverse transcription-polymerase chain reaction assay were employed to investigate the anticancer mechanisms of BLSEE (100, 200 and 400 µg/ml) in HCT-116 cells. BLSEE reduced HCT-116 cell proliferation in a dose-dependent manner. BLSEE treatment also significantly increased the sub-G1 population in HCT-116 cells (P=0.0020 at 400 µg/ml), as shown by flow cytometry assay. Following treatment with BLSEE, the mRNA levels of the apoptosis-associated factors Fas, Fas ligand, tumor necrosis factor-related apoptosis-inducing ligand, death receptor 4 (DR4), death receptor 5 (DR5), caspases 3, 8 and 9, and B-cell lymphoma-2 (Bcl-2) associated X protein were increased, and the expression of anti-apoptotic Bcl-2 and Bcl-extra large was decreased in HCT-116 cells. The mRNA levels of matrix metalloproteinase (MMP)-2, MMP-9, TIMP metallopeptidase inhibitor 1 and TIMP metallopeptidase inhibitor 2 were also regulated by BLSEE treatment. In addition, BLSEE was able to modulate the expression of inflammation-associated nuclear factor-κB, inhibitory κBα, inducible nitric oxide synthase and cyclooxygenase 2 in HCT-116 cells. The present study clearly indicated the cytotoxicity of BLSEE in HCT-116 cells through induced cellular apoptosis. These results also suggested the BLSEE may be a powerful agent against colon cancer cells.
IntroductionColorectal cancer (CRC) is one of the most frequently diagnosed cancers in the world. In the USA, CRC is the third most common malignant tumor, and there was an estimated 103,170 new cases of CRC throughout the country in 2014 (1). Previously, CRC has become the fourth most common malignant tumor, and the third leading cause of cancer-associated mortality in China (2). CRC also shows a high level of metastasis, and 25% of CRC patients that present with metastatic disease have a 5-year survival of only 10% (3). Surgical resection plus chemotherapy and/or radiation therapy are effective treatments for CRC in the clinic. However, chemotherapy and radiation therapy are commonly associated with serious side effects, including bone marrow suppression, nausea and vomiting, hair loss and loss of appetite (3). Enhancement of cancer cell apoptosis is a good strategy in the clinical treatment of cancer (4).As classic apoptosis-associated factors, the B-cell lymphoma 2 (Bcl-2) family plays an important role in the regulation of cell apoptosis. The Bcl-2 family is generally divided into anti-apoptotic factors, including Bcl-2, Bcl-extra large (Bcl-xL) and Bcl-W, and proapoptotic factors, including Bcl-2-associated X protein (Bax), Bcl-2 associated agonist of cell death, Bcl-2 interacting mediator of cell death (Bim), Bcl-2 antagonist/killer 1 and p53 upregulated modulator of apoptosis (5,6). In the extrinsic apoptosis pathway, the cell death receptor Fas/Fas ligand (FasL) system plays...